News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Nektar Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Business
Bay Area’s Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly
July 24, 2017
·
3 min read
Biotech Bay
Bay Area Nektar’ Comeback is Stalled as the EMA Rejects Breast Cancer Drug
July 21, 2017
·
2 min read
Biotech Bay
Nektar Therapeutics: A Sweet Or Sour Investment?
June 15, 2017
·
1 min read
Drug Development
For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug
March 20, 2017
·
3 min read
Drug Development
Nektar Therapeutics To Present At Jefferies Autumn 2015 Global Healthcare Conference In London
November 17, 2015
·
2 min read
Drug Development
Nektar Therapeutics Chief Science Officer Provides Details on Immuno-Oncology, Pain Pipelines
October 9, 2015
·
4 min read
Business
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
June 2, 2015
·
5 min read
Policy
Nektar Therapeutics Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry
March 17, 2015
·
4 min read
Job Trends
Booming Nektar Therapeutics (CA) Grabs More Mission Bay Space; May Hire Another 150 Staffers
January 20, 2015
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Nektar Therapeutics Reports First Quarter 2022 Financial Results
May 5, 2022
·
9 min read
Biotech Bay
Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
April 25, 2022
·
9 min read
Drug Development
Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15 Receptor Agonist, in combination with CAR Cell Therapies at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
April 23, 2022
·
8 min read
Biotech Bay
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors to Outline New Strategic Plan
April 22, 2022
·
1 min read
Biotech Bay
Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)
April 14, 2022
·
46 min read
Business
Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma
March 14, 2022
·
45 min read
Drug Development
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors Following Announcement of Update from Bristol-Myers Squibb and Nektar on the PIVOT-IO-001 Phase 3 Trial
March 14, 2022
·
1 min read
Business
Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
February 28, 2022
·
15 min read
Business
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2021 on Monday, February 28, 2022, After Close of U.S.-Based Financial Markets
February 17, 2022
·
1 min read
Biotech Bay
Nektar Therapeutics’ President and CEO, Howard Robin, to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
January 5, 2022
·
1 min read
